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Approximately 10% of circulating peripheral blood lymphoid cells belong to 
the  large  granular  lymphocyte (LGL) population.  LGL  exhibit  characteristic 
cytomorphology,  histochemical  properties,  and  monoclonal  antibody-defined 
cell  surface markers  (reviewed  in  1 and  2).  They mediate natural  killer (NK) 
activity and antibody-dependent, cell-mediated cytotoxicity (ADCC) and may act 
as a first line of resistance against foreign cells, microorganisms, and tumor cells 
(1,  2).  The lineage derivation of LGL is unclear and has not been conclusively 
identified by phenotypic and functional studies. Several reports (1, 2) have shown 
that  LGL are  heterogeneous and share characteristics of both  T  lymphocytes 
(e.g.,  T1 1,  T10,  T8  expression  and  interleukin  2  [IL-2]  responsiveness)  and 
mononuclear phagocytes (e.g.,  Moi expression,  IL-1  production, and cytotoxic 
activity of broad specificity against tumor cell lines).  It has also been suggested 
that LGL may belong to a separate lineage (3). 
Rarely, pathologic proliferations occur in  humans in cells displaying several 
features of LGL, including morphology, cytochemistry, NK-related cell surface 
markers,  high ADCC, and, in some cases, spontaneous NK activity (for review 
see 4). These LGL expansions have been variously referred to as chronic T'y cell 
leukemia, T"/ iymphocytosis, or T'y lymphoproliferative disease (T-y LPD [4]). 
We investigated (5) the organization of the gene coding for the beta chain of the 
T  cell receptor (T/3) in LGL expansions occurring in  12 patients with T3, LPD. 
Based on the fact that the T/3 gene rearranges early during the T  cell differen- 
tiation pathway (6), our study was aimed at elucidating the relationship between 
LGL/NK and T  cells in terms of lineage derivation and immune function. 
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Materials and  Methods 
Patients and Cell Samples.  All  12 patients exhibited peripheral blood and bone marrow 
infiltration by cells displaying characteristic LGL morphology, i.e., abundant moderately 
basophilic cytoplasm, numerous azurophilic granules, round nuclei, and absent nucleoli. 
LGL were isolated from  12 patients with T3, LPD by Ficoil-Hypaque density gradient 
centrifugation of freshly drawn heparinized peripheral blood,  followed by depletion of 
adherent  monocytes on  plastic.  Normal  LGL were  obtained  from  healthy  donors  as 
described by Timonen and Saksela (7) on a discontinuous 35-47.5%  gradient of Percoll 
(Pharmacia, Inc., Uppsala, Sweden), with minor modification. 
Monoclonal  Antibody-defined  Cell  Surface  Markers  and  Morphology.  The  membrane 
phenotype of the isolated cells was determined by indirect immunofluorescence using a 
Zeiss  microscope  and/or  a  FACS  IV  (Becton  Dickinson  Immunocytometry Systems, 
Mountain  View, CA).  The following panel of monoclonai antibodies was used:  OKT3, 
OKT6, OKT8, OKT 11, and OKM 1 (Ortho Diagnostic Systems Inc., Raritan, NJ or gifts 
of Dr. E. Reinherz, Dana-Farber Cancer Institute, Boston, MA); HNK-1 (8), reactive with 
NK  cells  and  a  subset  of T  cells  (courtesy  of Dr.  T.  Abo,  University  of Alabama, 
Birmingham, AL); B73.1 (2) (courtesy of Dr. G. Trinchieri, Philadelphia, PA) and AB8.28 
(9) (courtesy of Dr.  Malavasi, University of Torino, Torino, Italy), both reactive with a 
structure closely associated with the Fc"r receptor of LGL; N901, reactive with LGL and 
some myeloid precursors (10) (courtesy of Dr. J. Griffin, Dana-Farber Cancer Institute, 
Boston, MA). 
Cytotoxicity Assays.  NK activity was assessed by using the K562 cell line at effector/ 
target cell (E/T) ratios of 25:1 to 100:1, in a 4 h 5~Cr-release  assay, as previously described 
(11).  For ADCC, S~Cr-labeled  TLX9 murine  lymphoma cells,  sensitized with  1:10,000 
rabbit antibody, were used as targets in a 4 h test (12). 
In a series of experiments, effector cells (2 ×  106/ml in RPMI 1640 medium with 10% 
pooled  human  serum)  were  cultured  for  72  h  with  IL-2.  Supernatant  of the  gibbon 
lymphosarcoma line MLA 144 (50% final concentration,  100 U/mi) (13) or recombinant 
IL-2 (100 #g/ml) (a gift of Dr. J.  Schindler,  Biogen  Research Corp.,  Cambridge,  MA) 
were the I L-2 sources. Cytotoxicity was assessed against K562 cells or against the relatively 
NK-resistant  Daudi  line.  We  will  refer  to  IL-2-induced  cytotoxicity  as  lymphokine- 
activated killer (LAK) function, as suggested by others (14).  Results are presented as the 
percentage of specific lysis (mean +  SD, three replicates per group) after subtraction of 
spontaneous release in the absence of effectors. 4-6% differences above background were 
statistically significant. 
DNA Extraction and Southern Blot Analysis.  DNA was prepared by cell lysis, proteinase 
K digestion, extraction with phenol, and precipitation with ethanol (15).  15 #g of DNA 
were digested with the appropriate restriction endonuclease, electrophoresed in a  0.8% 
agarose gel, denatured, neutralized, transferred to a nitrocellulose filter, and hybridized 
according to Southern (15).  Filters were washed in 0.2 × SSC, 0.5 sodium dodecyl sulfate 
(SDS), pH 7 at 60°C for 2 h. 
DNA  Probes.  The  TB probe  was  derived  from a  human  cDNA  T~8 clone  (YTJ-2) 
isolated from the Jurkat-2 T  lymphoma cell line (courtesy of Dr. Tak Mak) (5). This clone 
hybridizes to both alleles (C0~ and C02) of the constant region and to one or more alleles 
of the  variable regions (5,  16).  The generation  of fragments specific for the constant 
(T¢~C) region have been previously described (16).  DNA fragments were s2P-labeled by 
nick translation for use as probes (15). 
Results 
Table I summarizes the principal immunophenotypic and functional properties 
of the LGL isolated from each of the  12 cases of T~ LPD. In each case, the LGL 
expressed the T 11 sheep erythrocyte receptor, the NK cell surface marker HNK- 
1,  and  Fc~  receptors  identified  by  rosetting  techniques  (data  not  shown),  by 
AB8.28  or  by  B73.1  monoclonal  antibodies,  and  by ADCC  effector function. T
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FIGURE  1.  T/3 gene rearrangements in T3' LPD cases. DNA was extracted from LGL derived 
from the same T'r LPD cases illustrated in Table I. DNA were digested with the indicated 
restriction enzymes and hybridized to a T/3 probe representative of the constant region of the 
TI3 gene (TBC). 
Surface markers T3, T8, OKM1, and N901  were detected in the LGL isolated 
from some but not all cases.  All  LGL were negative for T6.  LGL from all T'y 
LPD patients  had high  ADCC,  whereas  high  NK activity was  only detected in 
cases 2,  4, and  11.  LGL from T3, LPD (except patient 9), on cultivation in the 
presence of IL-2 for 72 h,  developed high lytic activity against both K562 and 
the  more  resistant  Daudi  cells.  LGL cultured  in  medium  alone  showed  some 
enhancement of lytic activity (up to 40% specific lysis against K562) in one case 
(No.  12). 
We analyzed the  organization  of TI3C  by Southern  blot hybridization using 
Eco RI or Bam HI restriction enzymes, and a TBC probe. Results are summarized 
in Table I and illustrated  in  Fig.  1. The cells isolated from nine cases exhibited 
bi-allelic  deletion  of the  Eco  RI  12.0  kb  DNA  fragment,  a  pattern  we  have 
previously shown to be characteristic of both polyclonal and monoclonal imma- 
ture and mature T  cell populations (16). Clonal rearrangements of the TI3C gene 
were demonstrated in five of these nine cases, indicated by the presence of new 
hybridization bands that were not detectable in control DNA (see bands marked 
by arrow in cases 3, 4,  7, and  10 in Fig.  1).  In the remaining four cases (Nos. 5, 
9,  11, and 12), clonal rearrangements were found when the extracted DNA were 
digested  with  Barn  HI,  thus  demonstrating  the  monoclonal  nature  of all  nine 
cases of T3' LPD. The LGL isolated from the three remaining cases (Nos.  1,  2, 
and 6) displayed the germline Eco RI band pattern. However, Bam HI digestion 
demonstrated the presence of clonally rearranged bands in case 6. The remaining 
two cases (Nos.  1 and 2) displayed an intact germline TI3C locus upon digestion 
with  Eco RI,  Bam  HI  (see  Fig.  1),  and  Hind  III  (not shown).  It is  noteworthy 
that these two T/3 gene-unrearranged cases did not appreciably express the T3 
antigen (Table I). We conclude that T3' LPD are heterogeneous in the organi- 2160  T/3  GENE  REARRANGEMENTS  IN  LGL/NK  PROLIFERATIONS 
zation of the T/3 gene. The more frequently encountered cases of T3 + T3' LPD 
show clonal rearrangements  (T3÷T/3  + T'y LPD), whereas the less common T3- 
T3' LPD exhibit the germline T/3 configuration (T3-T/3- Ty LPD). 
Discussion 
Our results appear to divide the  12 cases of Ty LPD into two distinct groups, 
based on their expression of the T3 antigen and on rearrangements  of the T~ 
gene.  Both  T3+T~ +  and  T3-T~=  T'r  LPD  usually  expressed  and,  in  most 
instances,  coexpressed,  the  T  cell-restricted  antigens  T ll  and  T8  and  the 
myeloid-associated antigent Mol. Most notably, an analogous pattern was found 
in clonal NK populations derived from normal cells; i.e., both T3+T~+T~ + and 
T3-T~-Ta-  NK clones exist and both groups are heterogeneous in the expres- 
sion of the T8 and  Mol antigens (18,  19).  These observations indicate that the 
immunogenotypic and immunophenotypic heterogeneity of these Ty LPD cases 
is not due to lineage infidelity, a phenomenon occasionally observed in hemato- 
poietic tumors.  Conversely, these neoplastic cases suggest the existence of two 
normal  NK subpopulations that  (a) are  distinguishable  by the  presence  of T~ 
gene rearrangements  and  T3 antigen  expression, and (b) express T8 and  Mol 
antigens. 
The  existence of two LGL/NK subpopulations can  be explained  by at  least 
two possibilities. First, they may reflect two separate differentiation lineages. For 
example, T3+T~  + NK clones and tumors may represent proliferations of periph- 
eral  T  cells  displaying  NK-like  phenotype,  morphology,  and  functions,  while 
T3-T~-  cells  may  belong  to  a  non-T  cell-related  lineage.  Alternatively,  a 
common differentiation pathway may exist in which,  together with the appear- 
ance (or disappearance)  of various lymphoid or myelomonocytic markers (e.g., 
T8 and Mol antigen),  LGL/NK cells can acquire the ability to express the T3/T 
cell  antigen  receptor  complex.  This  latter  possibility  is  supported  by  recent 
studies  from  our  laboratories  (Pelicci,  manuscript  submitted  for  publication) 
showing that peripheral blood LGL/NK cells do not express the T3 antigen, do 
contain a  germline  T~ gene, and do not express T~ or To~ mRNA.  However, 
T~  gene  rearrangements  and  expression,  accompanied  by  Ta  gene  and  T3 
antigen expression, can be induced in vitro in a  T8 + LGL/NK cell subset upon 
cultivation with IL-2. These findings suggest the existence of an IL-2-dependent 
LGL/NK differentiation  pathway  that  appears  to  be clearly  distinct  from  the 
conventionally defined T  cell lineage, based on a number of features including: 
(a) its thymus independence, (b) the expression of specific LGL markers, and (c) 
the coexpression of T8 and Mol antigens.  We propose that  LGL isolated from 
patients  with  Ty  LPD  may represent  expansions  of cells blocked at  different 
stages of differentiation/activation within the LGL/NK hematopoietic lineage(s). 
The  often chronic,  noninvasive clinical  behavior of Ty  LPD has  led  to the 
hypothesis  that  it  represents  a  reactive  rather  than  a  neoplastic  process (20). 
However, our studies demonstrate  that the cellular expansion is monoclonal  in 
origin,  at least in  the Ty  LPD cases displaying T~ gene rearrangements.  It is 
intriguing that the majority of cases of T'r  LPD are TS+T3 + when the majority 
of peripheral  blood  normal  LGL/NK  cells  are  T~8-T 3-.  The  latter  finding RAMBALD1  ET  AL.  2161 
suggests  that  a  presumably  more  differentiated/activated  target  is  frequently 
involved in T3, LPD. 
Summary 
Twelve  cases  of T3'  LPD  (lymphoproliferative disorders  of Fcy  receptor- 
bearing T  cells) involving an  expansion  of large  granular  lymphocyte/natural 
killer (LGL/NK) cells were investigated for the expression of LGL/NK-associated 
markers and for T0 gene rearrangement.  All the cases selected were classified 
as T3' LPD on the basis of morphology, function, and phenotype of the circulating 
cells.  10  to  12  cases  displayed  clonai  rearrangements  of  the  TO  locus  and 
expression  of  the  T3  antigen,  whereas  the  2  remaining  cases  displayed  the 
germline configuration of the TO gene and no expression of the T3 antigen. T8, 
Mol, B73.1, and  N901  antigens  were variably expressed among both T/3+T3  + 
and T/3-T3- T3, LPD cases. We suggest that individual T3, LPD cases represent 
the clonal expansion of cells frozen at different stages of differentiation/activa- 
tion within an individual hematopoietic LGL/NK lineage. 
We are grateful to Tak Mak for the T/3 probe, to Diane Nazario for careful editing of 
the manuscript, and to S. Carding for critically reviewing the manuscript. 
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